Fact CheckerSign in

NCT05584228Not yet recruiting

Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease

SyMptomAtic Stricturing Small Bowel CRohn's Disease - Medical Treatment Versus Surgery, a Prospective, Multi-centre, Randomized, Non-inferiority Trial

Source: ClinicalTrials.gov · Last updated 23 Jun 2026

Brief summary (registry, in English)

The objective of the SMART trial is to compare a combination therapy using azathioprine and subcutaneous infliximab versus ileocecal resection in patients with symptomatic small bowel Crohn's disease.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
150 (estimated)
First submitted
26 Sept 2022
Start date
1 Oct 2026
Primary completion date
1 Apr 2030
Lead sponsor
Nantes University Hospital
NCT number
NCT05584228

What you commit to

  • Study type: Interventional
  • Planned participants: 150
  • From 1 Oct 2026 to the primary completion date, 1 Apr 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Acute bowel obstruction requiring urgent surgical intervention
  • Concurrent active perianal sepsis
  • Contra-indication to surgery, general anesthesia, anti-TNF, thiopurines
  • Use of corticosteroids (prednisolone \> 20 mg daily or equivalent) within 4 weeks prior to visit V0
  • Treatment with any biologics within 8 weeks before visit V0

Other illness

  • Suspected or confirmed gastrointestinal perforation
  • Internal fistulizing disease in association with strictures
  • Colonic stenosis and/or colonic active disease at screening endoscopy
  • HIV/HCV/HBV infection

Other

  • Adults under guardianship, safeguard justice or trusteeship
  • Pregnant or breastfeeding female
  • Presence of a stoma

Who the study is looking for

  • Age between 18 and 70 years
  • Male or female
  • Documented small bowel CD with intestinal stricture(s) identified on CT, MRI or endoscopy, AND responsible for obstructive symptoms
  • CREOLE score \> 2

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de Nantes
Coordinator of this site? Confirm its status
NantesFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.